DEUTSCHE BANK AG\ - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 16 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$2,000
-33.3%
6,0000.0%0.00%
Q4 2015$3,000
-25.0%
6,0000.0%0.00%
Q3 2015$4,000
-50.0%
6,000
-33.3%
0.00%
Q2 2015$8,000
+33.3%
9,000
+50.0%
0.00%
Q1 2015$6,000
-64.7%
6,000
-66.7%
0.00%
Q4 2014$17,00018,0000.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
BVF INC/IL 10,000,000$3,550,0000.43%
Telemetry Investments, L.L.C. 2,500,000$875,0000.33%
UBS OCONNOR LLC 7,500,000$2,780,000,0000.05%
View complete list of OREXIGEN THERAPEUTICS INC shareholders